FDA Recalls and Corrective Actions
17 Sep 2024Managing products’ integrity and efficacy in an enormous supply chain (such as that of the US) could be quite challenging. Faulty and harmful products often need to be recalled from the market, to guarantee public safety from their effects. In the USA, Medical device recalls are typically started voluntarily by the manufacturer under 21 CFR Part 7. In rare cases where a manufacturer or importer fails or not recall a device that poses health risks, the FDA may issue a recall order of 21 CFR 810, known as the Medical Device Recall Authority. Procedures for compliance with are described in the section 518(e) of the Federal Food, Drug, and Cosmetic Act.
Under 21 CFR 806, Medical Device; Report of Corrections and Removals, manufacturers and importers must report to the FDA:
– Regarding any correction or removal of a medical device if it was done to reduce health risks posed by the device.
– To address violations of the Act that could affect the health of the patients.
Read about other articles on FDA compliance like FDA Labeling and Instructions for Use – Medical Devices and FDA’s Post-Market Surveillance and Reporting for Medical Devices
Important Definitions Considering FDA Recalls
1) Correction: An action intended to repair, change, adjust, relabel, destroy or enhance a medical device in use or available in the market to make it compliant to regulations and minimize the risk associated to the public health.
2) Market Withdrawal: Removal or correction of a medical device that involves in a minor issue not warranting legal action by the FDA, or no issue at all, such as routine equipment repairs or normal stock rotation practices.
3) Recall: A voluntary action undertaken by the manufacturer or the distributor to remove or correct a marketed product that the FDA deems to violate its administered laws and might lead to serious health consequences or cause death. A recall specifically excludes actions like market withdrawals or stock recoveries.
4) Recall Strategy: A planned strategy or procedures how a specific recall will be conducted, covering details such as the scope of the recall, whether public warnings are necessary, how notified the recall to the customer and the extent of effectiveness checks to ensure the recall’s success.
5) Recalling Firm: The company that starts a recall or, where the FDA requests a recall, the company primarily responsible for manufacturing and marketing the product being recalled.
6) Removal: Actions intended to withdraw a device from its current location to another place for repair, modification, change, relabeling, destruction, or inspection.
7) Risk to Health: It means either (1) there’s a high chance that using the product will lead to serious health problems or death, or (2) using the product could cause temporary or medically reversible health issues, or an outcome where the likelihood of serious health problems is very low.
8) Routine Servicing: Routine maintenance activity to be conducted on a device, such as replacing parts when they reach the end of their typical lifespan, like calibration, battery replacement, and addressing wear and tear. Repairs due to unexpected issues (as per correction), replacing parts prematurely, or fixing multiple units of a device in the same way are not considered routine servicing.
9) Stock Recovery: Fixing or removing a device that hasn’t been sold or sent on the market by the manufacturer. This includes devices still on the manufacturer’s premises, with none of the affected batch, model, code, or unit having been released for sale or use.
Voluntary Recalls – 21 CFR 7
Recall is used by the FDA to correct or remove products that violate its regulations after distribution. 21 CFR 7 outlines procedures for the FDA to oversee recalls and evaluate how well the manufacturers handle them. Manufacturers and distributors can start recalls voluntarily, or the FDA may request one. FDA recall requests are reserved for urgent situations and are directed to the firm primarily responsible for making and selling the product in question. Recall specifically excludes market withdrawal or stock recovery. Market withdrawal refers to a firm correcting or removing a distributed product for minor violations, not warranting FDA legal action or for situations like routine equipment repairs or normal stock rotation. Nearly all recalls are started voluntarily by the manufacturer.
Classifications of Recalls
According to 21 CFR, Part 7a recall could be classified into three different categories:
• Class I – It refers to a situation in which there’s a high likelihood that using or being exposed to a product that violates regulations will lead to severe health problems or death.
• Class II – It refers to a situation in which using or being exposed to a product that violates regulations could cause temporary or reversible health issues, or where the chance of severe health problems occurring is very low.
• Class III – It refers to a situation in which using or being exposed to a product that violates regulations is unlikely to cause any harmful health effects.
Termination of a Recall
A recall ends when the FDA confirms that all necessary steps have been taken to remove or correct the product as planned in the recall strategy. This includes ensuring that the recalled product has been removed appropriately or fixed based on its level of risk. When all the activities are completed, the recalling firm sends to FDA an official notification which informs that the recall is ended. A recall report was included in the notification in which are available all the steps and activities conducted, recall efficacy and the mitigation evidence of the mitigated public health risk.
Additional Guidance on Recalls
A recall can disrupt a company’s operations and business, but firms can take proactive steps to minimize these disruptions. Alongside requirements in the Quality System regulation (21 CFR 820), firms should consider:
- Developing and keeping an up-to-date written plan for initiating and carrying out a recall as per 21 CFR 7 guidelines.
- Implementing clear coding on products to ensure easy identification of specific batches and enable efficient recall of all affected batches.
- Maintaining distribution records of products that support locating recalled items. These records should be kept for a duration longer than the product’s shelf life and expected usage, meeting at least the minimum time required by relevant record retention regulation stated in 21 CFR 820.180. As it says: “All records required by this part shall be kept for a period equivalent to the design and expected life of the device, but in no case less than 2 years from release for commercial distribution by the manufacturer”.
Do you Find Dealing with Product Recalls difficult?
A product recall can be quite hectic for both manufacturers and distributors. The entire process has to fulfill several FDA requirements. With the help of our consultants at TSQ& Engineering, we will ensure that your product recalls comply with the all the relevant FDA requirements. We will also help you take CAPA (Corrective and Preventive Actions) in this specific topic. To learn more, ask us today!
